Cargando…

The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus

Biofilms are responsible for persistent or recurring microbial infections. Polymicrobial biofilms are prevalent in environmental and medical niches. Dual-species biofilms formed by Gram-negative uropathogenic Escherichia coli (UPEC) and Gram-positive Staphylococcus aureus are commonly found in urina...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Inji, Jailani, Afreen, Lee, Jin-Hyung, Ahmed, Bilal, Lee, Jintae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301033/
https://www.ncbi.nlm.nih.gov/pubmed/37376127
http://dx.doi.org/10.3390/pharmaceutics15061679
_version_ 1785064716752650240
author Park, Inji
Jailani, Afreen
Lee, Jin-Hyung
Ahmed, Bilal
Lee, Jintae
author_facet Park, Inji
Jailani, Afreen
Lee, Jin-Hyung
Ahmed, Bilal
Lee, Jintae
author_sort Park, Inji
collection PubMed
description Biofilms are responsible for persistent or recurring microbial infections. Polymicrobial biofilms are prevalent in environmental and medical niches. Dual-species biofilms formed by Gram-negative uropathogenic Escherichia coli (UPEC) and Gram-positive Staphylococcus aureus are commonly found in urinary tract infection sites. Metal oxide nanoparticles (NPs) are widely studied for their antimicrobial and antibiofilm properties. We hypothesized that antimony-doped tin (IV) oxide (ATO) NPs, which contain a combination of antimony (Sb) and tin (Sn) oxides, are good antimicrobial candidates due to their large surface area. Thus, we investigated the antibiofilm and antivirulence properties of ATO NPs against single- and dual-species biofilms formed by UPEC and S. aureus. ATO NPs at 1 mg/mL significantly inhibited biofilm formation by UPEC, S. aureus, and dual-species biofilms and reduced their main virulence attributes, such as the cell surface hydrophobicity of UPEC and hemolysis of S. aureus and dual-species biofilms. Gene expression studies showed ATO NPs downregulated the hla gene in S. aureus, which is essential for hemolysin production and biofilm formation. Furthermore, toxicity assays with seed germination and Caenorhabditis elegans models confirmed the non-toxic nature of ATO NPs. These results suggest that ATO nanoparticles and their composites could be used to control persistent UPEC and S. aureus infections.
format Online
Article
Text
id pubmed-10301033
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103010332023-06-29 The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus Park, Inji Jailani, Afreen Lee, Jin-Hyung Ahmed, Bilal Lee, Jintae Pharmaceutics Article Biofilms are responsible for persistent or recurring microbial infections. Polymicrobial biofilms are prevalent in environmental and medical niches. Dual-species biofilms formed by Gram-negative uropathogenic Escherichia coli (UPEC) and Gram-positive Staphylococcus aureus are commonly found in urinary tract infection sites. Metal oxide nanoparticles (NPs) are widely studied for their antimicrobial and antibiofilm properties. We hypothesized that antimony-doped tin (IV) oxide (ATO) NPs, which contain a combination of antimony (Sb) and tin (Sn) oxides, are good antimicrobial candidates due to their large surface area. Thus, we investigated the antibiofilm and antivirulence properties of ATO NPs against single- and dual-species biofilms formed by UPEC and S. aureus. ATO NPs at 1 mg/mL significantly inhibited biofilm formation by UPEC, S. aureus, and dual-species biofilms and reduced their main virulence attributes, such as the cell surface hydrophobicity of UPEC and hemolysis of S. aureus and dual-species biofilms. Gene expression studies showed ATO NPs downregulated the hla gene in S. aureus, which is essential for hemolysin production and biofilm formation. Furthermore, toxicity assays with seed germination and Caenorhabditis elegans models confirmed the non-toxic nature of ATO NPs. These results suggest that ATO nanoparticles and their composites could be used to control persistent UPEC and S. aureus infections. MDPI 2023-06-08 /pmc/articles/PMC10301033/ /pubmed/37376127 http://dx.doi.org/10.3390/pharmaceutics15061679 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Park, Inji
Jailani, Afreen
Lee, Jin-Hyung
Ahmed, Bilal
Lee, Jintae
The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus
title The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus
title_full The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus
title_fullStr The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus
title_full_unstemmed The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus
title_short The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus
title_sort antibiofilm effects of antimony tin oxide nanoparticles against polymicrobial biofilms of uropathogenic escherichia coli and staphylococcus aureus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301033/
https://www.ncbi.nlm.nih.gov/pubmed/37376127
http://dx.doi.org/10.3390/pharmaceutics15061679
work_keys_str_mv AT parkinji theantibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus
AT jailaniafreen theantibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus
AT leejinhyung theantibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus
AT ahmedbilal theantibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus
AT leejintae theantibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus
AT parkinji antibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus
AT jailaniafreen antibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus
AT leejinhyung antibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus
AT ahmedbilal antibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus
AT leejintae antibiofilmeffectsofantimonytinoxidenanoparticlesagainstpolymicrobialbiofilmsofuropathogenicescherichiacoliandstaphylococcusaureus